<DOC>
	<DOCNO>NCT00003050</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness radiation therapy plus paclitaxel treating patient stage IIB stage III breast cancer .</brief_summary>
	<brief_title>Radiation Therapy Plus Paclitaxel Treating Patients With Stage IIB Stage III Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate safety feasibility twice week paclitaxel radiation therapy patient locally advance breast cancer . II . Determine pathological effect paclitaxel radiation locally advance breast cancer . OUTLINE : This nonrandomized , dual institution study . Patients receive paclitaxel IV 1 hour twice week total 8 week . This start within 1 week tumor biopsy . Patients receive radiotherapy 5 days/week 5.0 week within 1 week first paclitaxel dose . Operable patient progressive disease therapy undergo modify radical mastectomy ( MRM ) , receive 4 course doxorubicin IV cyclophosphamide IV , administer every 21 day . Inoperable patient receive chemotherapy regimen , reevaluate surgery . Patients stable disease respond paclitaxel/radiation regimen undergo MRM , receive 4 course doxorubicin IV paclitaxel IV ( 3 hour ) every 21 day . All patient hormone receptor positive tumor receive tamoxifen 5 year therapy complete . PROJECTED ACCRUAL : A total 40 patient ( 20 patient per institution ) accrue 18- 24 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven , untreated , locally advanced breast cancer ; stage IIB ( T3 N0 ) , IIIA , IIIB Measurable disease Not inflammatory breast cancer stage IIB ( T2 N1 ) No distant metastasis except positive ipsilateral supraclavicular node PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant Fertile patient must use effective contraception 6 month treatment Medically psychologically stable PRIOR CONCURRENT THERAPY : No prior therapy type</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>